Icu Medical (ICUI) Income from Continuing Operations (2009 - 2026)
Icu Medical's (ICUI) quarterly Income from Continuing Operations came in at $16.1 million in Q2 2026, down 50.54% on a YoY basis from $32.5 million in Q2 2025, and down 47.71% quarter-over-quarter from $30.7 million in Q1 2026.
Analysis
Icu Medical (ICUI) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Icu Medical (ICUI) has reported Income from Continuing Operations for 18 consecutive years, with $16.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Income from Continuing Operations fell 50.54% year-over-year to $16.1 million; the trailing twelve-month figure through Jun 2026 stood at $31.7 million (up 179.7% YoY), and the FY2025 full-year result was $1.9 million, up 101.63% from the prior year.
- Income from Continuing Operations retreated to $16.1 million in Q2 2026 per ICUI's latest filing, from $30.7 million in the prior quarter.
- Across five years, Income from Continuing Operations topped out at $32.5 million in Q2 2025 and bottomed at -$39.5 million in Q1 2024.
- Historically, Income from Continuing Operations has averaged -$9.6 million across 5 years, with a median of -$13.2 million in 2022.
- The sharpest annual moves came in 2024 and 2026: Income from Continuing Operations tumbled 555.69% in 2024, then surged 298.62% in 2026.
- Over 5 years, Income from Continuing Operations stood at -$15.5 million in 2022, then slipped by 10.37% to -$17.1 million in 2023, then slumped by 38.96% to -$23.8 million in 2024, then soared by 44.4% to -$13.2 million in 2025, then soared by 221.32% to $16.1 million in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered $16.1 million, $30.7 million, and -$13.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | 249.10 Mn |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 383.43 Mn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | -92.00 Mn |
| 10 | Icu Medical | 3.82 Bn | 3.52 Bn | 235.05 Mn | 16.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.07 Mn |
| Mar 31, 2026 | 30.74 Mn |
| Dec 31, 2025 | -13.25 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Jun 30, 2025 | 32.50 Mn |
| Mar 31, 2025 | -15.48 Mn |
| Dec 31, 2024 | -23.83 Mn |
| Sep 30, 2024 | -32.98 Mn |
| Jun 30, 2024 | -21.41 Mn |
| Mar 31, 2024 | -39.47 Mn |
| Dec 31, 2023 | -17.15 Mn |
| Sep 30, 2023 | 7.24 Mn |
| Jun 30, 2023 | -9.93 Mn |
| Mar 31, 2023 | -9.81 Mn |
| Dec 31, 2022 | -15.54 Mn |
| Sep 30, 2022 | -13.21 Mn |
| Jun 30, 2022 | -7.47 Mn |
| Mar 31, 2022 | -38.07 Mn |
| Dec 31, 2021 | 19.93 Mn |
| Sep 30, 2021 | 31.08 Mn |